The company aims to conduct research, development, production, and marketing of bioelectronic and electroceutical medical devices, including related biomaterials and software, for applications in regenerative medicine. The company may establish subsidiaries and branches in Switzerland and abroad, participate in other domestic and foreign enterprises, acquire or merge with similar or related companies, and enter into any transactions and conclude any contracts that are suitable to promote the purpose of the company or are directly or indirectly related thereto. The company may acquire, hold, manage, encumber, exploit, and dispose of real estate, participations, financial instruments, intellectual property rights, and licenses in Switzerland and abroad. The company may conduct business with or for the benefit of related parties, including their direct and indirect shareholders and other affiliated companies, notably grant loans to these parties or issue guarantees, sureties, pledges, or other securities to secure their obligations, in any case whether for a fee or not and even if these legal transactions are exclusively in the interest of the related parties. The company may engage in any further activity that is directly or indirectly related to the aforementioned purposes.